SOX2 and non-small cell lung carcinoma: Recently, a number of studies have reported the contribution of SOX2 to tumorigenesis and itscorrelation with clinical progression of various types of tumors, including human breast cancer [13], rectal cancer [14], prostate cancer [15] and NSCLC [16], [17].